CAESAREA, Israel--(BUSINESS WIRE)--Itamar Medical, the world’s leading developer of non-invasive technology for early detection of cardiovascular disease and home testing of obstructive sleep apnea, continues to penetrate new markets and has announced a breakthrough in South America by receiving ANVISA certification. The flagship products, WatchPAT and EndoPAT, may now be imported and sold freely to the clinical market of South America.
